Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 9:58 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2593–2616 of 21,046 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: ONE Clear all

Conditions: Sepsis
Interventions: Septic patients, Healthy Control; Procedure
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 80 Years
Enrollment: 63 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Malaria
Interventions: GSK257049 Dosage 1, GSK257049 Dosage 2, Sporozoite-infected mosquitoes challenge; Biological · Procedure
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Silver Spring, Maryland

Conditions: Low Back Pain
Interventions: Intracutaneous sterile water injections (ISWI) group, Intracutaneous dry injections (IDI) group; Other
Lead sponsor: Lindsey schmelzer; Federal
Eligibility: 18 Years to 64 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Nellis Air Force Base, Nevada

Conditions: Eating Disorders
Interventions: Transdiagnostic Network Informed Personalized Treatment, Enhanced Cognitive Behavioral Therapy for Eating Disorders; Behavioral
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years to 65 Years
Enrollment: 320 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Hoarding Disorder
Interventions: Imaginal Exposure Writing, Neutral Writing; Behavioral · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Neuropathic Pain, PTSD
Interventions: Ketamine, Magnesium sulfate, Ketamine + Magnesium sulfate; Drug
Lead sponsor: Margaux M. Salas, PhD; Federal
Eligibility: 18 Years to 70 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Breast Cancer
Interventions: CoQ10, CoQ10 Placebo, Doxorubicin, Cyclophosphamide; Drug · Other
Lead sponsor: Columbia University; Other
Eligibility: 21 Years and older · Female only
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Help-Seeking Behavior, Pre-exposure Prophylaxis Use, Condomless Sex, Risky Health Behavior
Interventions: Moon and Sun Brothers: A Community Prevention Intervention; Behavioral
Lead sponsor: San Francisco State University; Other
Eligibility: 18 Years and older
Enrollment: 360 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: San Francisco, California • Chicago, Illinois

Conditions: Attitude of Health Personnel
Interventions: One-on-one physician training, Usual training; Other
Lead sponsor: The Reading Hospital and Medical Center; Other
Eligibility: 25 Years to 65 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: West Reading, Pennsylvania

Conditions: Hypertension
Interventions: Isosorbide Mononitrate, sustained release, Placebo capsule; Drug
Lead sponsor: Corporal Michael J. Crescenz VA Medical Center; Federal
Eligibility: 18 Years to 89 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Familial Chylomicronemia Syndrome (FCS) (HLP Type I)
Interventions: LCQ908; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Seatlle, Washington

Conditions: Pregnancy Related, Anemia, Iron Deficiency
Interventions: Ferumoxytol Injection [Feraheme], Ferrous Sulfate; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Stanford, California

Conditions: Heart Failure
Interventions: Placebo, Sodium Nitrite, Accelerometer, Cardiac Exercise Training; Drug · Device · Other
Lead sponsor: Barry Borlaug; Other
Eligibility: 40 Years and older
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Alcohol Abuse, Alcohol Use Disorder, Alcohol Drinking, Relations, Interpersonal, Military Family
Interventions: CRAFT Web-Based Intervention, Phone-Based CRAFT, CRAFT Workbook, Gottman Self-Guided Resources; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 744 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria, Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome, Chronic Myelogenous Leukemia, Chronic Lymphocytic Leukemia, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma, Waldenstrom Macroglobulinemia, Breast Cancer, Renal Cell Carcinoma, Melanoma, Sarcoma, Ovarian Cancer, Thymoma
Interventions: Nonmyeloablative Allogeneic Transplant; Procedure
Lead sponsor: Scripps Health; Other
Eligibility: 18 Years to 72 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2015
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Breast Cancer Prevention, Mammographic Density
Interventions: Ultrasound-guided core needle biopsy, Denosumab, Blood draw, Calcium, Vitamin D; Procedure · Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 35 Years and older · Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Osteoarthritis
Interventions: Osteoarthritis Intervention; Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 21 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Irritable Bowel Syndrome
Interventions: Pregabalin, Placebo; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 70 Years
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 2
States / cities: Rochester, Minnesota • La Crosse, Wisconsin

Conditions: Tobacco Use Disorder, Tobacco Dependence, Smoking
Interventions: Anatabloc(TM), CigRx(R); Dietary Supplement
Lead sponsor: Rock Creek Pharmaceuticals, Inc.; Industry
Eligibility: 23 Years to 72 Years
Enrollment: 109 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Martinsburg, West Virginia

Conditions: Surgical Incision
Interventions: Fractional Radiofrequency; Device
Lead sponsor: Venus Concept; Industry
Eligibility: 21 Years to 75 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Dentin Sensitivity
Interventions: 12027-019, 12027-020, 12027-021; Device
Lead sponsor: Johnson & Johnson Consumer and Personal Products Worldwide; Industry
Eligibility: 18 Years and older
Enrollment: 174 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Oral Malodor
Interventions: Brush / Espresso Mild Prototype, Brush / Espresso Intense Prototype, Brush / Fresh Breath Oral Rinse, Brush / Hydroalcohol; Other
Lead sponsor: Johnson & Johnson Consumer and Personal Products Worldwide; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 166 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Fort Wayne, Indiana

Conditions: Urothelial Carcinoma, Urothelial Cancer, Lung Neoplasms, Small Cell Lung Cancer, Prostate Cancer
Interventions: EP0057, olaparib, CT scan, CT chest, abdomen, and pelvis, Bone scan, ECG, Echocardiogram, Biopsy; Drug · Diagnostic Test · Procedure
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2025
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Basal Cell Carcinoma
Interventions: 5% Imiquimod cream, Placebo Vehicle Control Cream; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 1,630 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2032
U.S. locations: 8
States / cities: Long Beach, California • San Diego, California • Bay Pines, Florida + 5 more

Search by objective public record fields.

Hypoxia Inducible Factor 1 Alpha as a Novel Biomarker in Septic Shock

Efficacy, Safety and Immunogenicity Study of GlaxoSmithKline(GSK) Biologicals' Candidate Malaria Vaccine 257049 in the Sporozoite Challenge Model in Healthy Malaria-naïve Adults

Intracutaneous Sterile Water Injections for Acute Low Back Pain in the Emergency Department

Innovations in Personalizing Treatment Study

Imaginal Exposure for Hoarding Disorder

The Effect of Outpatient Ketamine Infusion on Chronic Neuropathic Pain and PTSD

Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer

Moon and Sun Brothers: A Community Prevention Intervention (Hermanos de Luna y Sol)

Educational Intervention to Increase Physician Satisfaction and Effectiveness With a New Electronic Health Record

Effect of Isosorbide Mononitrate on Hypertension to Improve Left Ventricular Hypertrophy, Fibrosis and Myocardial Function

Extension to a Randomized, Double-blind, Placebo Controlled Study of LCQ908 in Subjects With Familial Chylomicronemia Syndrome.

Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia

Inorganic Nitrite to Amplify the Benefits and Tolerability of Exercise Training in Heart Failure With Preserved Ejection Fraction (HFpEF) (INABLE-Training)

A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners

Nonmyeloablative Allogeneic Transplant

RANKL Inhibition and Breast Tissue Biomarkers

Patient and Provider Interventions for Managing Osteoarthritis in Primary Care

A Placebo-Controlled Trial of Pregabalin (Lyrica) for Irritable Bowel Syndrome

Study to Evaluate the Safety and Efficacy of Dietary Supplement Anatabloc in Reducing Daily Smokers' Urge to Smoke

Fractional Radiofrequency for Reduction of Surgical Scar Formation

Tooth Sensitivity Relief by Two Mouthrinses

Four-Week Oral Malodor and Clinical Safety for a Concentrated Cosmetic Mouthwash

Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer

Basal Cell Carcinoma Chemoprevention Trial